Want to see HK:8307 full AI Analyst Report?
8307 Stock Chart & Stats
HK$0.17
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.17
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.24
Previous CloseN/A
Volume16.00K
Average Volume (3M)24.27K
Market Cap
HK$48.80M
Enterprise ValueHK$42.34M
Total Cash (Recent Filing)HK$29.46M
Total Debt (Recent Filing)HK$17.57M
Price to Earnings (P/E)1180.0
Beta0.28
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding396,736,000
10 Day Avg. Volume55,600
30 Day Avg. Volume24,266
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)11.39
Price to Sales (P/S)1.24
P/FCF Ratio13.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Positive Free Cash FlowRepeat positive operating and free cash flow provides durable liquidity and internal funding optionality. Even with revenue swings, consistent FCF supports capex and debt servicing, reduces reliance on external capital, and creates a buffer that helps the company manage short-to-medium term volatility.
Sustained Positive EBITDA MarginsMid‑teens EBITDA margins over multiple years indicate structural operating efficiency and service economics. Those margins provide a persistent earnings cushion that supports cash generation, increases resilience to revenue downturns, and offers potential to restore net profitability if top line stabilizes.
Return To Net Profit In FY2026Transitioning back to positive net income demonstrates progress in cost control or mix improvements and shows the business can generate accounting profits. If sustained, this supports retained earnings accumulation, improves stakeholder confidence, and aids gradual balance-sheet repair over the medium term.
Bears Say
Elevated Leverage And Small Equity BaseVery high leverage relative to company history materially raises solvency and refinancing risk. A thin equity base reduces operational flexibility, increases vulnerability to earnings shocks, and limits capacity to absorb losses without resorting to external financing or dilutive measures.
Revenue Volatility And Recent DeclinesPersistent top-line volatility and consecutive declines impair planning and utilization of fixed costs. Weak revenue trends limit ability to convert healthy EBITDA margins into consistent net profits and cash flow, making medium-term margin and leverage improvements harder to achieve.
Gross Margin Deterioration And FCF DropA marked fall in gross margin alongside a large FCF decline weakens earnings quality and the liquidity cushion. Reduced gross profitability compresses operating leverage benefits and, combined with lower FCF, limits the company's ability to de‑lever or invest without external capital unless structural cost or pricing issues are resolved.
8307 FAQ
What was Medicskin Holdings Ltd.’s price range in the past 12 months?
Medicskin Holdings Ltd. lowest stock price was HK$0.02 and its highest was HK$0.24 in the past 12 months.
What is Medicskin Holdings Ltd.’s market cap?
Medicskin Holdings Ltd.’s market cap is HK$48.80M.
When is Medicskin Holdings Ltd.’s upcoming earnings report date?
Medicskin Holdings Ltd.’s upcoming earnings report date is Nov 16, 2026 which is in 103 days.
How were Medicskin Holdings Ltd.’s earnings last quarter?
Medicskin Holdings Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.
Is Medicskin Holdings Ltd. overvalued?
According to Wall Street analysts Medicskin Holdings Ltd.’s price is currently Overvalued.
Does Medicskin Holdings Ltd. pay dividends?
Medicskin Holdings Ltd. pays a Notavailable dividend of HK$0.025 which represents an annual dividend yield of N/A. See more information on Medicskin Holdings Ltd. dividends here
What is Medicskin Holdings Ltd.’s EPS estimate?
Medicskin Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medicskin Holdings Ltd. have?
Medicskin Holdings Ltd. has 396,736,000 shares outstanding.
What happened to Medicskin Holdings Ltd.’s price movement after its last earnings report?
Medicskin Holdings Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 22.549%.
Which hedge fund is a major shareholder of Medicskin Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:8307
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medicskin Holdings Ltd.
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
Technical Analysis
EuroEyes International Eye Clinic Limited
―
Raily Aesthetic Medicine International Holdings Limited
―
Beauty Farm Medical & Health Industry, Inc.
―
Arrail Group Ltd.
―
Saint Bella Inc.
―